Kingston Hospital NHS Foundation Trust runs Kingston Hospital, an acute NHS hospital in Kingston upon Thames, South West London. The Trust was licensed as an NHS Foundation Trust by Monitor from 1 May 2013. The Trust has been rated 'outstanding' by the CQC.

During the past decade, Kingston Hospital conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 1 clinical trials were completed, i.e. on average, 7.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kingston Hospital" #1 sponsor was "Institute of Cancer Research, United Kingdom" with 2 trials, followed by "MicroPort CRM" with 2 trials sponsored, "Royal Marsden NHS Foundation Trust" with 2 trials sponsored, "Aalborg University Hospital" with 1 trials sponsored and "Cancer Research UK" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kingston Hospital" #1 collaborator was "Barts & The London NHS Trust" with 1 trials as a collaborator, "British Heart Foundation" with 1 trials as a collaborator, "Chief Scientist Office of the Scottish Government" with 1 trials as a collaborator, "City, University of London" with 1 trials as a collaborator and "Copenhagen Trial Unit, Center for Clinical Intervention Research" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Kingston Hospital" are "Bradycardia" (2 trials), "Colorectal Cancer" (2 trials), "Crohn Disease" (2 trials), "Prostate Cancer" (2 trials) and "Breast Cancer Female" (1 trials). Many other conditions were trialed in "Kingston Hospital" in a lesser frequency.

Most popular intervention types in "Kingston Hospital" are "Drug" (4 trials), "Device" (3 trials), "Other" (3 trials), "Procedure" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abemaciclib" (1 trials), "Adalimumab (40 mg)" (1 trials), "Blood Samples for Biomarkers" (1 trials), "Carestream 3600 intra oral scan" (1 trials) and "Endocrine therapy (letrozole, anastrozole, exemestane or tamoxifen)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kingston Hospital" are 11 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Kingston Hospital". undefined are not yet recruiting, 6 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Kingston Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kingston Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".